Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

gene-editing

This page shows the latest gene-editing news and features for those working in and with pharma, biotech and healthcare.

Sangamo surges on data for haemophilia A gene therapy

Sangamo surges on data for haemophilia A gene therapy

nuclease (ZFN) gene-editing platform for rare disease Hunter syndrome. ... reduces risk in the company’s other gene therapy programmes which include candidates for Fabry disease, amyotrophic lateral sclerosis and Huntington’s disease.

Latest news

More from news
Approximately 4 fully matching, plus 34 partially matching documents found.

Latest Intelligence

  • Vertex: a vision of treating all CF patients worldwide draws closer Vertex: a vision of treating all CF patients worldwide draws closer

    A gene therapy cure for all the world’s CF patients would be a truly remarkable achievement. ... These include alpha-1 antitrypsin deficiency and focal segmental glomerulosclerosis. It’s also working with CRISPR Therapeutics on phase 1/2 clinical

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases? ... Meanwhile, CRISPR isn’t the only gene-editing technology being used in human therapeutics, although its devotees claim it is the simplest, easiest and

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    Gene editing as a therapeutic tool has ignited an explosion of excitement within the industry over the past few years: the science fiction concept of being able to simply remove and ... With an array of such tools in play, scientists seem to be on the

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    That means gene products hitting that Glybera price of $1m are, for now at least, unlikely. ... CRISPR Therapeutics, one of the companies working with the exciting cutting-edge CRISPR/Cas9 gene editing technology, is looking to begin a phase I trial with

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    23. Dr Kathy Niakan, Developmental Biologist, The Francis Crick Institute. The last few years have seen a huge surge of interest in new gene editing tools that have enormous potential as ... The greatest excitement is reserved for CRISPR-Cas9 gene editing

More from intelligence
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Eric Rhodes becomes CEO of ERS Genomics Eric Rhodes becomes CEO of ERS Genomics

    In these roles, Rhodes was responsible for commercialising the company's genome editing technologies as well as driving its research and development. ... Biosciences. Foy said: “With his deep understanding of the gene-editing landscape and extensive

  • Marc Becker joins CRISPR Therapeutics Marc Becker joins CRISPR Therapeutics

    He becomes chief financial officer. CRISPR Therapeutics has appointed Marc Becker as its new chief financial officer with remit to drive development of its gene-editing technology platform.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Random42 Partner with MedCity for BioJapan 2018

    J. Leading UK health scientists, universities and national research institutions will provide insight into the UK life sciences sector, and their work in ageing, gene editing and artificial intelligence.

  • Training the next generation of biotech leaders

    Novel technologies, coupled with programmes designed to drive cell and gene research and development, are ushering in a new era of therapies. ... It’s such a disruptive advancement – it’s just incredible to think it has all been made feasible

  • Perspective on biotech

    The emerging technologies revolutionising the biotech industry – from immunotherapy breakthroughs to cutting-edge gene editing techniques.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Quick links

Infographics

Multimedia